SCHEMBL2186388

SCHEMBL2186388

COc1cccc(CC2CC(C(=O)Nc3ccc(Oc4ccc(F)cc4)cc3)N(C(=O)Cn3cncn3)C2)c1

nearest known ligand 0.82

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 9/20 0.82
CYP2C9 P11712 6/20 0.82
CYP2D6 P10635 6/20 0.82
CYP3A4 P08684 3/20 0.80
FAAH O00519 1/20 0.42
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FPR1 P21462 1/20 0.38
FPR2 P25090 1/20 0.38
GRIN2B Q13224 1/20 0.38
CCR3 P51677 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1375581 1.00 S1PR1 (0.82) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2170136 0.93 S1PR1 (0.87) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1373052 0.93 S1PR1 (0.87) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1375520 0.92 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1373750 0.91 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2186351 0.91 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2170080 0.90 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1373685 0.90 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1374243 0.89 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1374743 0.89 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP claimed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO claimed
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed